Our daughter @KatieSimon has a great article in The Cut-New York Magazine as a prelude to her book about intimacy after sexual assault, Tell Me What You Want, coming out July 29th from Kensington Press. Preorders really help – @katiewsimon https://t.co/t9cVA5ZbNN
Thrilled to share with you that we have a zoom event today. This will be a great conversation about how local, no-till farming is playing a role in building a more resilient food system in the context of our changing climate. Register here: https://t.co/JBtIonWp7Y
We are thrilled to announce that Jeffrey Brown has joined @SensoriumTx to serve as Chief Scientific Officer.
Dr. Brown is a seasoned drug hunter with over 20 years experience in biotech and larger pharmaceutical companies.
Excited for this talk with MindSite News about the State of Play: Companies and Clinical Trials. Josh Hardman from Psychedelic Alpha will be joining me on December 10th at 10am PT. Register for this free event today: https://t.co/Z496qSQ5xx
Meet the Scientific Co-founders: Stephen Haggarty, PhD, helps direct our Biodynamic Discovery PlatformTM, and serves as Associate Professor of Neurology at Harvard Medical School & an Associate Neuroscientist at MGH, in addition to other notable roles and accomplishments.
Thank you Rowan Walrath and @BosBizJournal for spotlighting our Series A & mission to bring nature-inspired medicines to address our #MentalHealth crisis. Read more: https://t.co/XYBoqGfxda
Meet the Scientific Co-founders: Jacob Hooker, PhD, brings a chemist’s perspective to solving mysteries of the human #brain. He is Director of Radiochemistry at the Martinos Center for Biomedical Imaging & Scientific Director of the Lurie Center for Autism at MGH.
Many thanks to @PaulSchloesser and @endpts for sharing our Series A news this week—the financing will indeed fuel our journey of “mining” plants and fungi to bring forth novel medicines for #MentalHealth and #CNS disorders.
Read more: https://t.co/6FQO7aGW2k
Meet the Scientific Co-founders: Dr. Rosenbaum is Director, Center for the Neuroscience of Psychedelics & Stanley Cobb Professor of Psychiatry at Harvard Medical School. He shapes our clinical strategy to advance novel #MentalHealth treatments. For more: https://t.co/r8uqeNgy5d.
A note of gratitude to our wonderful investors: Sante Ventures, Route 66 Ventures, CU Healthcare Innovation Fund, WPSS, Palo Santo, Iter Investments, Ocama Partners, re.Mind Capital, and many others supporting our mission to reimagine the treatment paradigm for #mentalhealth
Loved chatting with Heather McKenzie and @biospace about our Series A news this week, including our unique approach to #CNS drug discovery and development and our world-class team. Thank you! https://t.co/8hL2vjqYMr
A great team has come together to realize Sensorium’s vision. Thanks to my co-founders Jacob Hooker, Jerry Rosenbaum, Steve Haggarty, Alex Simon and to all of the terrific people who have joined Pranav, Aaron, Gavin Daigle, Mike, Kelli, Irina, Carson, Monica, Alexa, and Komla.
With this capital, we look forward to bringing our initial candidate into clinical trials and leveraging our Biodynamic Discovery Platform to develop new therapeutics for mental health and a broad range of #CNS conditions.
I’m very excited to share the public launch of Sensorium Therapeutics and the close of our Series A financing, which enables us to advance our mission of alleviating human suffering by addressing the #MentalHealth crisis. https://t.co/u3LP2ZEXs1
A psychedelic drug boom in mental health treatment comes closer to reality https://t.co/9axccllZCC
Honored to be featured in this article about the potential mental health benefits of psychedelic assisted therapies.
Very excited by the well-deserved attention MGH’s Center for the Neuroscience of Psychedelics is receiving! https://t.co/GJNhcqldYR and https://t.co/dOvK4hMacf